The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are usually associated with loss of dopaminergic neurons. Loss of substantia nigra neurons and presence of Lewy body inclusions in some of the remaining neurons are the hallmark pathology seen in the final stages of the disease. Attempts to correlate Lewy body pathology to either cell death or severity of clinical symptoms, however, have not been successful. While the pathophysiology of the neurodegenerative process can hardly be explained by Lewy bodies, the clinical symptoms do indicate a degenerative process located at the presynapse resulting in a neurotransmitter deficiency. Recently it was shown that 90% or even more of alpha-synuclein aggregates in DLB cases were located at the presynapses in the form of very small deposits. In parallel, dendritic spines are retracted, whereas the presynapses are relatively preserved, suggesting a neurotransmitter deprivation. The same alpha-synuclein pathology can be demonstrated for PD. These findings give rise to the notion that not cell death but rather alpha-synuclein aggregate-related synaptic dysfunction causes the neurodegeneration. This opens new perspectives for understanding PD and DLB. If presynaptic alpha-synuclein aggregation, not neuronal loss, is the key issue of the neurodegenerative process, then PD and DLB may eventually be treatable in the future. The disease may progress via trans-synaptical spread, suggesting that stem cell transplants are of limited use. Future therapies may focus on the regeneration of synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PD is associated with four cardinal motor symptoms, including tremors, rigidity, bradykinesia, and postural instability, alongside the characteristic shuffling and stooped posture of the “Parkinsonian gait” [46].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“It could be demonstrated that the presence of symptoms may be related to the involvement of defined regions as measured by the occurrence of Lewy bodies [47–49], supporting the observations that the a-synuclein aggregation pathology spreads through the brain involving anatomical structures sequentially [13].”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“The discovery of mutations in the a-synuclein gene [77, 114, 156] and overexpression of a-synuclein [123] as being associated with Parkinson’s disease or dementia with Lewy bodies (DLB) strengthens the association between protein”
BackgroundParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 2×
“Tremor at rest, rigidity, akinesia/bradykinesia and postural instability are the four cardinal features in Parkinson’s disease [60].”
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“association between the frequency and extension of tangles and Ab-plaques and the occurrence of the disease [55, 104], Terry et al.”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“It was assumed that the cognitive impairment in AD is related to a synaptic failure [121, 124, 130].”
Background
Cited by
Items 601–664 of 664
The Role of Chaperones and Co-Chaperones in Synaptic Proteostasis and Neurodegenerative Disease
Sharma, N., Singh, R., Banerjee, S., & Kaushik, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_10
Role of Sulforaphane in Neurodegenerative Diseases: A Focus on Parkinson’s Disease
Ali, M. N., Goel, R., & Kumar, R. (2025) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v3i1.2025.163
Lewy pathology accumulates in enlarged corticostriatal synapses in α-synucleinopathies
Prigent, A., Singh, A., & Henderson, M. X. (2026) · Brain Communications · doi:10.1101/2025.08.27.672679
Exercise and cognitive function in aging
Kabeer, D. A., Singh, P., Bhat, Z. U. H., Cherappurath, N., Ahmed, T., & Hassan, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00007-9
Protein misfolding and aggregation and its role in dementia with Lewy bodies
Singh, V., Anamika, A., Chandra, N., Gupta, V., Gautam, P., Mishra, B., Sethi, A. K., Rath, S., & Mishra, V. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00005-5
Liu, X., Wang, Q., Yang, Y., Stewart, T., Shi, M., Soltys, D., Liu, G., Thorland, E., Cilento, E. M., Hou, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14183759
Caracterização da fosfatase String/Cdc25 como um regulador da neurotoxicidade de Tau em Drosophila
Rodrigues, D. R. M. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Identifying substrates of AD-associated PKC alpha and regulators of PD-associated LRRK2 degradation
Liu, M. (2023) · eScholarship (California Digital Library)
Évaluation de la présence d'une protéinopathie dans le tremblement essentiel
Aubry-Lafontaine, É. (2017) · Corpus Université Laval (Université Laval)
Targeting mitochondria as a potential therapeutic strategy in neurodegenerative disease
Hu, D. (2019) · OhioLink ETD Center (Ohio Library and Information Network)
Untersuchung des N. vagus mittels hochauflösenden Ultraschalls bei der Parkinsonerkrankung
Meißner, E. (2023) · Qucosa (Saxon State and University Library Dresden)
Axonal transport of lysosomes in glucocerebrosidase-deficient iPSC-derived neurons
Keefe, A., & Keefe, A. (2022) · Summit (Simon Fraser University)
Legault-Denis, C. (2024) · Archipel (Université du Québec à Montréal)
Picón, M. L. (2020) · Corpus Université Laval (Université Laval)
Concussions related to contact sports and their neurodegenerative consequences
Di Troia, B. (2023) · HAL
Cruz, B. M. D. L. (2020) · Nottingham ePrints (University of Nottingham)
da Silva, M. I. O. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9y1x-3112
Kuske, A.-S. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-48934
Benfante, V., Belloli, S., Faustini, G., Bellucci, A., Moresco, R. M., & Comelli, A. (2026) · Lecture notes in computer science · doi:10.1007/978-3-032-11317-7_20
Pathological TDP-43 filaments accumulate at synapses and cause synaptic dysfunctionPreprint
Chen, R., Stockwell, I., Pierce, J. C., Peak‐Chew, S., Huang, M., Newell, K. L., Ghetti, B. F., Cousin, M. A., Greger, I. H., & Falcon, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.27.701787 · Cited by 1
The role of ketamine in the L-DOPA-induced rat dyskinesia model
Tekin, N. (2024) · Dspace Repository (Marmara Üniversitesi)
Oehlwein, C., Netzel, L., Mittmann, K., Oehlwein, M., & Schulz‐Schaeffer, W. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1724003
“The dopamine depletion is related to a pre-synaptic aggregation of the synaptic protein α -synuclein (Kramer and Schulz-Schaeffer, 2007; Schulz-Schaeffer, 2010) and occurs together with disturbances in synaptic vesicle cycling (Scott and Roy, 2012).”
Self-citationGlial glucocorticoid geceptors in parkinsonism
Maatouk, L. (2015) · theses.fr (ABES) · doi:10.70675/1256b391z3e4fz471bz8360ze0eee3d095a8
Boudet-Devaud, F. (2018) · theses.fr (ABES) · doi:10.70675/111341b9z5eeez4531z8f07zcb44d6f469a0
Étude des bases cérébrales de la maladie à corps de Lewy par IRM multimodale
Chabran, E. (2019) · theses.fr (ABES) · doi:10.70675/0e043513z1fabz4531za279z1f82876b9864
Arnould, H. (2019) · theses.fr (ABES) · doi:10.70675/9f070729z72aez4fccz9604z8c52be1a62e6
Hamdaoui, Q. (2021) · theses.fr (ABES) · doi:10.70675/80460aadz3953z465dz98edz35fe1486c591 · Cited by 2
Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99
Développement et caractérisation de nouveaux modèles murins de maladie à corps de Lewy
Schueller, E. (2020) · theses.fr (ABES) · doi:10.70675/4a313736z3f42z4d92zb1c1ze3cbd7bbe9f6 · Cited by 1
Interaction entre l’α-synucléine et LRRK2 dans la maladie de Parkinson : focus sur l’autophagie
Lebourg, F. (2021) · theses.fr (ABES) · doi:10.70675/977c4f08zbf81z4b0fzad70z6ab2d9ddd57b
Ribeiro, L. W. (2023) · theses.fr (ABES) · doi:10.70675/68582d99z4406z4ad4zbd76z15927fb63da5
Figueiredo, I. D. (2024) · theses.fr (ABES) · doi:10.70675/e26318dazc588z42e6z90edz96ccb2ee6e71
Engineering artificial biomolecular condensates to study the aggregation of α-Synuclein
Piroska, M.-L. (2023) · theses.fr (ABES) · doi:10.70675/1d15bb63z3f2fz4a91z80f1z5086a39a5087
Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson’s disease pathogenesis
Darsono, W. H. W., Hwang, Y., Valencia, E., Gunawan, L., Hyeon, S. J., Ryu, H., Stein, T. D., Chang, M., Wulansari, N., & Lee, S. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194989
Torso, M., Tzaferou, D., Valotti, M., Hardwidge, J., Hardingham, I., Koychev, I. G., Guo, Q., Comley, R. A., Chance, S. A., & Ridgway, G. R. (2026) · Movement Disorders · doi:10.1002/mds.70298
Shanmuganathan, D. K., Pranav, D. H., & Ariharasivakumar, G. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100338
Synaptic attenuation by human alpha-synuclein depends on two amino acids in its C-terminal tail
Riba, J., Samuel, L., Stavsky, A., Adaoui, E., Ashkenazy, T., Sevilla-Sánchez, D., & Gitler, D. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107437
Imaging of Central Nervous System Disorders of Protein Folding
Saini, J. S., Johnson, A. C., Prasad, S., & Soni, N. (2026) · Seminars in Roentgenology · doi:10.1016/j.ro.2026.150989
Deconvolving the structural heterogeneity of alpha-Synuclein in vitro and in situPreprint
Malinovska, L., Malinovska, A., Feng, Y., Verbeke, L., Kumari, P., Camino, J. D., Cappelletti, V., Kroschwald, S., Dultz, E., Tatlı, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727349
Subtypes of speech and language disorders in prodromal dementia with Lewy bodies
Heimlichová, K. (2026) · Brno University of Technology Digital Library (Brno University of Technology)
Krishnan, D., Lakshman, N., Fenwick, E. A., Muthuswamy, K., & Sivasamy, R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.021
Wang, T., Tzeng, I., Chen, Y.-C., & Chen, M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070694
Wang, X., Chen, K., Zhang, X., Ji, Y., Cheng, W., Shi, G., Fang, X., Zhang, Y., & Zhang, L. (2026) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-2026-0746
Rumpf, S.-L., Struebing, F. L., Nalbach, K., Vargiu, C. M., Berg, G., Lichtenthaler, S. F., Parchi, P., Gao, P., Weilin, C. H. E. N., Brendel, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74961-6
“These fi ndings cumulated in the “ dying back ” hypothesis, where synaptic dysfunction, including presynaptic degeneration, occurs before neuronal death, with α Syn aggregates impairing synaptic function 71,117,118 .”
Rooprai, S. (2026) · York University Digital Library (York University)
Natale, G., Carluccio, M. D., Campanelli, F., Marino, G., Nutarelli, S., Servillo, F., Canonichesi, J., Lentini, N., Pastorino, R., Chiurchiù, V., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115942
Synthetic Protein Mimetic Based Therapies for Neurodegeneration
Stillman, N. H. (2025) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2025.171
Yang, Z., Tang, Y., Wen, J., Guo, C., Zhou, Y., Wang, Z., Pan, T., Tan, Y., Perrett, S., Wu, S., et al. (2026) · JACS Au · doi:10.1021/jacsau.6c00631
Popa, L. L., Nicolaie, A., Maștaleru, A., Socolov, Ș., Mitrea, M., Popescu, G., Schreiner, T. G., Covali, R. A., Cucu, L.-E., Dima-Cozma, L. C., et al. (2026) · Medical Sciences · doi:10.3390/medsci14040489
Bougea, A. M. (2026) · Genes · doi:10.3390/genes17080965
“Within the hippocampal–cortical memory system, the LTP/LTD imbalance degrades encoding and consolidation; hippocampal volume may be relatively preserved early in DLB, underscoring that the deficit is initially functional and synaptic rather than atrophic [9,81].”
InfluentialTargeting Aberrant Protein-Protein Interactions in Cancer and Neurodegenerative Diseases
Ball, T. D. (2025) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2025.222
Lizama, B. N., Shin, R. S., North, H. A., Look, G., Reaver, A., Pandey, K., Duong, D., Seyfried, N. T., Caggiano, A. O., & Hamby, M. E. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00321-1
AI-driven transcriptomics for neurodegenerative disease research: A systematic review
Tripathi, A., Yadav, A. K., & Kumar, N. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109448
Therapeutic potential of positive allosteric modulators of AMPA receptors in brain disorders
Spinola, A., Italia, M., & Gardoni, F. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119960
Nguyen, N., Yuan, M., & Wang, Y. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04201-5
Quantification of brainstem depigmentation using neuromelanin-MRI in ageing and Parkinson's disease
Sapuan, A. H. (2023) · Nottingham ePrints (University of Nottingham)
Molecular Mechanisms of PFAS Induced Protein Dysfunction: Implications for Neurodegenerative Risk
Wilson, D. L. (2026) · scholarworks - UTEP (The University of Texas at El Paso)
Limitations of current neuroprotective therapies in dementia with Lewy bodies
O’Shea, D. M., Disla, S., Gosling, A. E., Valdelamar, G. A., Tolea, M. I., & Galvin, J. E. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2742316
Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact
Lopez, F. V., Erani, F. R., Bangen, K. J., Coughlin, D. G., Galasko, D. R., & Thomas, K. R. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70531
Natural products in the management of Parkinson's disease in animal models
Desouky, M. A., Abdelhamid, A. H., Gamal, N. K., Naeem, A. G., Sabry, N. C., Fahmy, S. M., Hanna, D. M. F., & Michel, H. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-54032-5.00010-3
BindingDB (2012) · UC San Diego · doi:10.7270/q2251jj4
BindingDB Entry 50040112: Synthesis and in vitro evaluation ofa-synuclein ligands.
BindingDB (2013) · UC San Diego · doi:10.7270/q25b03j1
Characterization of genetic markers for sporadic amyotrophic lateral sclerosis
Theunissen, F. (n.d.) · Murdoch University Research Portal
On α-synuclein in the Human Enteric Nervous System
Gray, M. T. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3568
“4.2.1 Vagal innervation αsyn aggregation and Lewy pathology begins not in the soma but at the presynaptic axon terminal (Chung et al., 2009; Kramer and Schulz-Schaeffer, 2007; Nakata et al., 2012; Schulz-Schaeffer, 2010; Tanji et al., 2011).”
BackgroundInfluential
Metadata
- Authors
- Schulz-Schaeffer, W. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-06-20
- Volume
- 120
- Issue
- 2
- Pages
- 131-143
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2892607
- OpenAlex
- W2033827101
- Cited by
- 627
- References
- 165
- Citations by year
- 2026: 38 · 2025: 51 · 2024: 45 · 2023: 24 · 2022: 43 · 2021: 48 · 2020: 48 · 2019: 41 · 2018: 40 · 2017: 35 · 2016: 36 · 2015: 29 · 2014: 41 · 2013: 36 · 2012: 35
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- GRO (submittedVersion, cc-by)
- Funders
- Volkswagen Foundation (ZN 2168)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein aggregation, Lewy bodies, dementia with Lewy bodies, Parkinson's disease, Parkinson's disease dementia, presynaptic dysfunction, synaptic pathology, neurotransmitter deficiency, neurodegeneration, trans-synaptic spread, stem cell transplantation, synapse regeneration
- MeSH terms
- Animals, Brain, Parkinson Disease, Synapses, Lewy Body Disease, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.